|
Name |
2,6-Dimethylbenzaldehyde
|
Molecular Formula | C9H10O | |
IUPAC Name* |
2,6-dimethylbenzaldehyde
|
|
SMILES |
CC1=C(C(=CC=C1)C)C=O
|
|
InChI |
InChI=1S/C9H10O/c1-7-4-3-5-8(2)9(7)6-10/h3-6H,1-2H3
|
|
InChIKey |
QOJQBWSZHCKOLL-UHFFFAOYSA-N
|
|
Synonyms |
2,6-Dimethylbenzaldehyde; 1123-56-4; BENZALDEHYDE, 2,6-DIMETHYL-; MFCD00128003; m-Xylene-2-carboxaldehyde; 2,6-DiMethyl-Benzaldehyde; 2,6-dimethylbenzaldehyd; 2,6-Dimethyl benzaldehyde; SCHEMBL66979; 2,6-Dimethylbenzaldehyde, 97%; DTXSID40342693; ZINC2582001; BBL103183; CL8253; STL556993; AKOS005255233; CS-W007640; PS-6110; SY002379; DB-005896; A2257; AM20050097; D3681; FT-0633367; EN300-82115; A802559; W-204781; F8889-9343; Z1233237340
|
|
CAS | 1123-56-4 | |
PubChem CID | 583841 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 134.17 | ALogp: | 2.1 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.54 |
Caco-2 Permeability: | -4.321 | MDCK Permeability: | 0.00002670 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.061 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.956 | Plasma Protein Binding (PPB): | 80.34% |
Volume Distribution (VD): | 1.289 | Fu: | 20.56% |
CYP1A2-inhibitor: | 0.93 | CYP1A2-substrate: | 0.89 |
CYP2C19-inhibitor: | 0.712 | CYP2C19-substrate: | 0.804 |
CYP2C9-inhibitor: | 0.108 | CYP2C9-substrate: | 0.734 |
CYP2D6-inhibitor: | 0.043 | CYP2D6-substrate: | 0.867 |
CYP3A4-inhibitor: | 0.091 | CYP3A4-substrate: | 0.334 |
Clearance (CL): | 5.672 | Half-life (T1/2): | 0.666 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.021 |
Drug-inuced Liver Injury (DILI): | 0.109 | AMES Toxicity: | 0.671 |
Rat Oral Acute Toxicity: | 0.026 | Maximum Recommended Daily Dose: | 0.569 |
Skin Sensitization: | 0.693 | Carcinogencity: | 0.576 |
Eye Corrosion: | 0.978 | Eye Irritation: | 0.997 |
Respiratory Toxicity: | 0.972 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000364 | 0.545 | D01PJR | 0.422 | ||||
ENC000179 | 0.485 | D0X0RI | 0.409 | ||||
ENC000649 | 0.459 | D0X4RN | 0.352 | ||||
ENC000552 | 0.459 | D0WO8W | 0.328 | ||||
ENC000414 | 0.405 | D0G7DJ | 0.306 | ||||
ENC000180 | 0.378 | D0U3DU | 0.302 | ||||
ENC000614 | 0.378 | D09RHQ | 0.297 | ||||
ENC000390 | 0.366 | D0E9CD | 0.295 | ||||
ENC000239 | 0.361 | D0H7AV | 0.292 | ||||
ENC000240 | 0.361 | D0A0FL | 0.284 |